Deng Jia, Tian Lixing, Ma Xiaoyuan, Fan Xia, Hou Fengyan, Liang Huaping, Luo Yan
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Mar;28(3):225-9.
To investigate the protective effect of agmatine (AGM) against peritoneal inflammatory response and neutrophil (PMN) infiltration induced by zymosan (ZYM) in mice.
Thirty-six adult male C57BL/6 mice were randomly divided into sham group, model group, and AGM treatment group. Peritonitis model was reproduced by intra-peritoneal injection of 1 mg/mL ZYM (0.5 mL), while equivalent phosphate buffer saline (PBS) was given to sham group. 200 mg/kg AGM was injected into peritoneal cavity after ZYM challenge in AGM treatment group. Six mice in each group were sacrificed at 2 hours and 6 hours, respectively, after reproduction of the model. Blood sample and peritoneal lavage fluid (PLF) were collected. The levels of keratinocyte-derived chemokine (KC), macrophage inflammatory protein 2 (MIP-2), tumor necrosis factor-α (TNF-α), interleukins-6 (IL-6) in serum and PLF were determined by enzyme linked immunosorbent assay (ELISA). The number of leukocytes and PMN in PLF were determined by hemocytometer and flow cytometry, respectively.
Compared with sham group, all serum and PLF levels of KC, MIP-2, TNF-α and IL-6 were greatly elevated at 2 hours after ZYM injection in model group, while AGM treatment could dramatically reduce the levels of the above-mentioned cytokines in serum and PLF as compared with those of the model group [serum KC (ng/L): 990.7±137.9 vs. 2 053.2±262.7, MIP-2 (ng/L): 642.2±124.4 vs. 1 369.7±146.5, TNF-α (ng/L): 608.6±38.1 vs. 1 044.7±101.0, IL-6 (ng/L): 1 058.2±129.1 vs. 1 443.3±190.1; PLF KC (ng/L): 7 462.3±839.6 vs. 12 723.5±1 515.7, MIP-2 (ng/L): 1 570.8±193.4 vs. 3 471.4±384.7, TNF-α (ng/L): 1 115.8±156.7 vs. 1 499.2±231.2, IL-6 (ng/L): 2 646.5±223.2 vs. 3 126.7±291.4; all P < 0.05]. The expressions of KC, MIP-2 and TNF-α at 6 hours were significantly lower than those at 2 hours in model group and AGM treatment group, but IL-6 levels were further increased. The levels of KC and MIP-2 in serum and PLF at 6 hours were decreased to the levels of sham group. At 6 hours after the reproduction of the model, the number of total inflammatory cells and PMN of PLF in the model group was significantly higher than those of the sham group. In contrast, AGM notably lowered the number of inflammatory cells and PMN in peritoneal fluid after ZYM attack [total inflammatory cells (×109/L): 14.7±1.1 vs. 2.0±0.4, 10.1±1.2 vs. 14.7±1.1; PMN (×109/L): 11.37±1.22 vs. 0.18±0.05, 7.69±0.57 vs. 11.37±1.22, all P < 0.05].
AGM can effectively alleviate acute peritoneal inflammatory injury induced by ZYM, mainly through reducing the secretion of inflammatory mediators and chemokines, and inhibiting the infiltration of leukocytes and neutrophils.
探讨胍丁胺(AGM)对酵母聚糖(ZYM)诱导的小鼠腹膜炎症反应和中性粒细胞(PMN)浸润的保护作用。
将36只成年雄性C57BL/6小鼠随机分为假手术组、模型组和AGM治疗组。通过腹腔注射1mg/mL ZYM(0.5mL)复制腹膜炎模型,假手术组给予等量磷酸盐缓冲盐水(PBS)。AGM治疗组在ZYM攻击后腹腔注射200mg/kg AGM。每组分别于造模后2小时和6小时处死6只小鼠,采集血样和腹腔灌洗液(PLF)。采用酶联免疫吸附测定(ELISA)法测定血清和PLF中角质形成细胞衍生趋化因子(KC)、巨噬细胞炎性蛋白2(MIP-2)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平。分别采用血细胞计数板和流式细胞术测定PLF中白细胞和PMN数量。
与假手术组相比,模型组ZYM注射后2小时血清和PLF中KC、MIP-2、TNF-α和IL-6水平均显著升高,而AGM治疗组与模型组相比,可显著降低上述细胞因子在血清和PLF中的水平[血清KC(ng/L):990.7±137.9 vs. 2053.2±262.7,MIP-2(ng/L):642.2±124.4 vs. 1369.7±146.5,TNF-α(ng/L):608.6±38.1 vs. 1044.7±101.0,IL-6(ng/L):1058.2±129.1 vs. 1443.3±190.1;PLF KC(ng/L):7462.3±839.6 vs. 12723.5±1515.7,MIP-2(ng/L):1570.8±193.4 vs. 3471.4±384.7,TNF-α(ng/L):1115.8±156.7 vs. 1499.2±231.2,IL-6(ng/L):2646.5±223.2 vs. 3126.7±291.4;均P<0.05]。模型组和AGM治疗组6小时时KC、MIP-2和TNF-α的表达明显低于2小时时,但IL-6水平进一步升高。6小时时血清和PLF中KC和MIP-2水平降至假手术组水平。造模后6小时,模型组PLF中总炎性细胞和PMN数量明显高于假手术组。相比之下,AGM显著降低了ZYM攻击后腹腔液中炎性细胞和PMN数量[总炎性细胞(×109/L):14.7±1.1 vs. 2.0±0.4,10.1±1.2 vs. 14.7±1.1;PMN(×109/L):11.37±1.22 vs. 0.18±0.05,7.69±0.57 vs. 11.37±1.22,均P<0.05]。
AGM可有效减轻ZYM诱导的急性腹膜炎症损伤,主要通过减少炎性介质和趋化因子的分泌,抑制白细胞和中性粒细胞浸润。